Lattice Biologics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '21 Jun 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017	Sep '16 Sep 30, 2016
Revenue	1.56	2.46	2.19	1.16	2.74	3.78
Revenue Growth (YoY)	-28.88%	12.60%	89.48%	-57.84%	-27.49%	-9.80%
Cost of Revenue	0.91	1.28	1.19	0.56	2.09	2.88
Gross Profit	0.65	1.18	1	0.59	0.64	0.9
Selling, General & Admin	0.92	1.14	1.35	1.72	2.72	3.79
Research & Development	-	-	0.01	0	0.22	0.07
Operating Expenses	1.26	1.52	1.58	2.08	3.46	5.73
Operating Income	-0.62	-0.34	-0.59	-1.48	-2.81	-4.84
Interest Expense	-0.83	-1.04	-0.54	-0.47	-0.47	-1.04
Other Non Operating Income (Expenses)	0.58	-0.02	0.12	0.25	0.32	-0.27
EBT Excluding Unusual Items	-0.86	-1.39	-1.01	-1.7	-2.96	-6.15
Merger & Restructuring Charges	-	-	-	-	-0.14	-
Asset Writedown	-	-	-	-	-0.3	-
Other Unusual Items	-0.09	-0.09	-	0.47	1.88	-1.7
Pretax Income	-0.95	-1.48	-1.01	-1.23	-1.52	-7.85
Net Income	-0.95	-1.48	-1.01	-1.23	-1.52	-7.85
Net Income to Common	-0.95	-1.48	-1.01	-1.23	-1.52	-7.85
Shares Outstanding (Basic)	127	103	93	93	78	48
Shares Outstanding (Diluted)	127	103	93	93	78	48
Shares Change (YoY)	33.86%	9.76%	0.00%	19.82%	61.99%	82.81%
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.16
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.02	-0.16
Free Cash Flow	-0.7	-0.06	0.11	0.03	-0.77	-2.18
Free Cash Flow Per Share	-0.01	-0.00	0.00	-	-0.01	-0.04
Gross Margin	41.44%	47.93%	45.58%	51.35%	23.54%	23.72%
Operating Margin	-39.52%	-13.63%	-26.76%	-128.48%	-102.74%	-128.07%
Profit Margin	-61.08%	-60.16%	-46.23%	-106.58%	-55.66%	-207.84%
Free Cash Flow Margin	-44.92%	-2.27%	5.01%	2.88%	-28.28%	-57.75%
EBITDA	-0.26	-0.06	-0.38	-1.28	-2.59	-4.36
EBITDA Margin	-16.99%	-2.44%	-17.43%	-111.06%	-94.58%	-115.42%
D&A For EBITDA	0.35	0.28	0.2	0.2	0.22	0.48
EBIT	-0.62	-0.34	-0.59	-1.48	-2.81	-4.84
EBIT Margin	-39.52%	-13.63%	-26.76%	-128.48%	-102.74%	-128.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.